"Cardiac Rehabilitation in Patients With Hypertrophic Cardiomyopathy".

NCT ID: NCT03178357

Last Updated: 2019-03-26

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-07-10
• Study Completion Date: 2020-12-31

Brief Summary

Hypertrophic cardiomyopathy (HCM) is the most common hereditary disease characterized by left ventricular hypertrophy and consequently left ventricular diastolic dysfunction. Its prevalence is estimated at around 0.2% in the general population. HCM is the most common cause of sudden cardiac death due to cardiovascular disease in young athletes, accounting for one third of deaths. HCM patients often have symptoms of heart failure. The ESC recommendations for heart failure (HF) from 2016 recommend exercise training regardless of ejection fraction to improve exercise capacity, quality of life, and reduction in hospitalizations due to HF. Meanwhile, for many years, HCM was equivalent to exercise training limitation. According to the 2014 ESC guidelines, it is recommended for patients with HCM to avoid sports practice. However the results of Edelmann et al. research, suggest that physical training leads to a significant clinical improvement in patients with diastolic dysfunction and thus may be beneficial in patients with HCM. In 2015 results of a first study were published (Klempfner et al.), which showed that the majority of HCM patients with moderate risk undergoing supervised physical training had improved physical performance and no significant adverse events were recorded. The study was limited by the small number of admitted patients (twenty), lack of control group and failure to perform cardio-pulmonary exercise test.

The main goal of the study will be to evaluate the effectiveness and safety of comprehensive cardiological rehabilitation and telerehabilitation in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction with preserved systolic function. The study is planned to include 30 patients with HCM subjected to physical training and 30 patients with HCM in the control group treated as standard according to current guidelines, not subjected to physical training.

Detailed Description

The main goal of the study will be to evaluate the effectiveness and safety of comprehensive cardiological rehabilitation and telerehabilitation in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction with preserved systolic function. The study is planned to include 30 patients with HCM subjected to physical training and 30 patients with HCM in the control group treated as standard according to current guidelines, not subjected to physical training.

Conditions

Cardiac Rehabilitation

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

HCM patients with CR

30 HCM patients treated as standard subjected to 4-week hospital cardiac rehabilitation (CR) including psychological care (counseling and / or psychoeducation) and physical training followed by 8 weeks of telerehabilitation in the patient's home (cardiac rehabilitation + standard therapy)

Group Type: OTHER

Cardiac rehabilitation + standard therapy

Intervention Type: OTHER

Patients with HCM subjected to cardiological rehabilitation

HCM patients without CR (control group)

30 HCM patients in control group - standard treatment according to current guidelines and outpatient visits with psychological and / or psychoeducational counseling (standard therapy)

Group Type: OTHER

Standard therapy

Intervention Type: OTHER

Standard treatment according to current guidelines and outpatient visits with psychological and / or psychoeducational counseling

Interventions

Cardiac rehabilitation + standard therapy

Patients with HCM subjected to cardiological rehabilitation

Intervention Type: OTHER

Standard therapy

Standard treatment according to current guidelines and outpatient visits with psychological and / or psychoeducational counseling

Intervention Type: OTHER

Other Intervention Names

Standard therapy

Eligibility Criteria

Inclusion Criteria

1. Patient with hypertrophic cardiomyopathy (defined in accordance with the ESC guidelines for the diagnosis and management of cardiomyopathy and hypertrophy in 2014): thickness ≥ 15 mm of one or more segments of the left ventricular wall measured using any imaging technique [echocardiography, cardiac magnetic resonance or computed tomography] which can not be explained solely by the left ventricular loading conditions) without left ventricular outflow tract obstruction at rest: gradient <30 mmHg.

2. Stable general condition (1 month period).

3. NYHA Class II and III.

4. Preserved LV systolic function (LVEF ≥ 50%).

5. Condition after ICD implantation.

6. Written informed consent of the patient to participate in the Program.

7. Completed eighteen years of age.

Exclusion Criteria

1. Complex life-threatening ventricular arrhythmias that can not be treated.

2. Uncontrolled hypertension.

3. Advanced atrio-ventricular block.

4. Myocarditis or pericarditis (up to 6 months).

5. Symptomatic aortic stenosis.

6. Acute systemic illness.

7. Intracardiac thrombosis.

8. Significant ischaemia during low intensity exercise test (2 METS, 50W).

9. Uncontrolled diabetes.

10. Pulmonary embolism (up to 6 months).

11. Thrombophlebitis.

12. New episode of AF/Afl.

13. Decrease in systolic blood pressure during exercise.

14. Co-morbidities that limit exercise tolerance and prevent exercise.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institute of Cardiology, Warsaw, Poland

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Krzysztof Sadowski

Role: PRINCIPAL_INVESTIGATOR

The Cardinal Stefan Wyszyński Institute of Cardiology

Locations

The Cardinal Stefan Wyszyński Institute of Cardiology

Warsaw, Masovian Voivodeship, Poland

Site Status: RECRUITING

Countries

Poland

Central Contacts

Krzysztof R Sadowski, MD

Role: CONTACT

ksadowski@ikard.pl

+48223434408

Facility Contacts

Krzysztof R Sadowski, MD

Role: primary

ksadowski@ikard.pl

+483434408

Other Identifiers

2.1/I/17

Identifier Type: -

Identifier Source: org_study_id